Recent research highlights the potential of targeting the brain’s metabolism to treat Alzheimer’s disease, a condition that disrupts cognitive functions like memory and thinking. Scientists from Stanford’s Knight Initiative for Brain Resilience, along with collaborators from institutions like the Salk Institute and Penn State University, have been investigating how to restore healthy brain function by focusing on the kynurenine pathway, a key regulator of brain metabolism. The brain’s metabolism relies on glucose, the fuel that powers neurons, which are crucial for thought and memory. Alzheime…